Author: Marcel Besier, Senior Director, Services Delivery, EMEA
Managing clinical trials in today’s increasingly complex landscape is a demanding task, often requiring the orchestration of multiple processes to ensure patient consent, drug dispensation, and outcomes data collection run smoothly. With phase three clinical trials generating an average of 3.6 million data points—a three-fold increase across a decade—the demands on site teams have never been greater. As trial technology portfolios expand to support and expedite research, they may inadvertently introduce new burdens on already overwhelmed site teams.
In this context, a unified technology platform can be an invaluable tool to help sites and sponsors seamlessly integrate the essential tools across the patient journey—such as eConsent to IRT and eCOA—into a single interface. Reducing integrations and simplifying overall trial management can offer a lifeline to site teams and sponsors.
Here’s how a unified patient management platform with eConsent, IRT and eCOA can simplify operations for sites and sponsors, especially in complex trials:
With eConsent, IRT, and eCOA seamlessly interoperable as a single software platform, Suvoda provides study teams with a central command center to efficiently manage their operations. What’s more, we marry our technology, deep expertise in trial protocols and therapeutic domains, and single project team service-model to partner with sponsors and sites to navigate uncertainties, changes and mid-trial amendments effectively. This service-oriented tech approach helps sites and sponsors create easy-to-use workflows and secure data sharing across the clinical trial journey—meaning less time spent on technology and more time devoted to testing potentially lifesaving therapeutics.